- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Jun 27, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,530 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
FWRY | ج.م6.50 | 15.0% | 15.7% | ج.م22.1b | ج.م8.17 | PE27.6x | E33.0% | n/a | Diversified Financials | ||
CADLR | NOK 66.90 | 6.2% | 49.5% | NOK 23.5b | NOK 74.85 | PS18.9x | E62.6% | n/a | Capital Goods | ||
AESI | US$19.77 | 1.9% | 10.8% | US$2.2b | US$27.08 | PE16.6x | E45.7% | 4.3% | Energy | ||
MVW | NOK 7.95 | -1.9% | 24.2% | NOK 260.1m | NOK 12.00 | PS24.1x | E69.0% | n/a | Materials | ||
AGP | €7.15 | -4.0% | 96.4% | €123.8m | €12.75 | PE25.2x | E22.8% | n/a | Capital Goods | ||
KEBNI B | SEK 1.62 | -2.9% | 30.6% | SEK 439.8m | SEK 2.20 | PS4.8x | E90.4% | n/a | Tech | ||
VOW | NOK 6.61 | 15.2% | -48.8% | NOK 752.5m | NOK 11.00 | PB1.9x | E97.6% | 0% | Commercial Services | ||
CALTX | SEK 205.60 | 0.4% | 140.0% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
ERO | CA$29.81 | 3.5% | 10.2% | CA$3.1b | CA$34.50 | PE36.4x | E61.1% | n/a | Materials | ||
OSE | €5.86 | -7.1% | 74.1% | €127.5m | €7.15 | PS57.2x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$17.95 | 5.7% | -25.5% | US$2.5b | US$31.50 | PE62.4x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.32 | -4.0% | -13.1% | SEK 80.5m | SEK 8.00 | PS3.5x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
GIG | NOK 29.75 | 3.1% | 20.7% | NOK 4.0b | NOK 45.03 | PE19.1x | E36.9% | n/a | Consumer Services | ||
AXSM | US$80.09 | 6.5% | 9.5% | US$3.7b | US$123.75 | PS15.2x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
MBTN | CHF 0.011 | 35.4% | -98.2% | CHF 253.9m | n/a | PS1.9x | E83.4% | n/a | Semiconductors | ||
KCHOL | ₺224.50 | 0.2% | 116.5% | ₺569.3b | ₺260.96 | PE9.1x | E38.8% | 3.6% | Capital Goods | ||
GGP | UK£0.073 | 0.7% | 2.8% | UK£371.6m | n/a | PB7.4x | E57.1% | n/a | Materials | ||
CRDO | US$31.29 | 10.3% | 78.3% | US$4.9b | US$29.42 | PS26.8x | E60.9% | n/a | Semiconductors | ||
ADOC | €8.70 | 15.4% | 119.7% | €128.1m | €9.70 | PS21.2x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$157.96 | 27.9% | 40.7% | US$14.8b | US$197.81 | PE883.6x | E39.4% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$123.99 | -5.2% | 203.7% | US$3.1t | US$131.78 | PE71.5x | E22.7% | 0.03% | Semiconductors | ||
EH | US$13.59 | -3.3% | -11.1% | US$863.2m | US$24.98 | PS39.8x | E74.3% | n/a | Capital Goods | ||
7373 | JP¥1,805.00 | 3.7% | -33.4% | JP¥27.5b | JP¥4,600.00 | PE24.2x | E28.1% | n/a | Commercial Services | ||
DIRR3 | R$26.82 | 6.2% | 36.5% | R$4.6b | R$30.36 | PE11x | E21.5% | 1.8% | Consumer Durables |